Manufacturing

How to validate adhesive bonding processes for medical devices — covering ISO 13485 Clause 7.5.6 and FDA QMSR requirements, UV curing and epoxy bonding process variables, IQ/OQ/PQ protocols, critical process parameters, surface preparation controls, adhesive chemistry selection (cyanoacrylate, UV-curable, epoxy, silicone), destructive testing strategy, revalidation triggers, and ongoing monitoring under FDA and EU MDR.

How to lock down antibody clones, manage lot-to-lot bridging studies, and maintain immunoassay performance across manufacturing campaigns — covering recombinant vs hybridoma strategies, critical quality attribute monitoring, bridging study design, and regulatory expectations under FDA QMSR, ISO 13485, and EU IVDR.

How to qualify battery cell suppliers and design battery packs for portable medical devices — covering lithium-ion chemistry selection (NMC, LFP, LCO, LTO), IEC 62133-2 and UN 38.3 compliance, Battery Management System requirements, FDA QMSR traceability, EU Battery Regulation due diligence, conflict minerals sourcing, lot-to-lot cell matching, incoming inspection, quality agreement structure, and dual-sourcing strategies for infusion pumps, ventilators, wearable monitors, and other Class II/III portable medical devices.

How to source biological specimen raw materials — human serum, plasma, urine, CSF, and tissue-derived matrices — for IVD calibrator and control manufacturing, including donor qualification, viral testing, traceability, TSE/BSE compliance, lot-to-lot consistency, and regulatory requirements under FDA 21 CFR 610, EU IVDR, and ISO 13485.

How to establish metrological traceability of calibrators and controls for in vitro diagnostic kits — covering ISO 17511:2020 calibration hierarchy models, JCTLM reference materials, WHO international standards, certified reference materials, commutability assessment, measurement uncertainty budgeting, value assignment protocols, and regulatory expectations under FDA, EU IVDR, and ISO 13485.

How to structure RACI matrices in CDMO quality agreements for sub-tier supplier control — defining who is responsible, accountable, consulted, and informed across OEM, CDMO, and sub-tier suppliers under ISO 13485, FDA QMSR, and EU MDR.

How to qualify and control coatings and surface treatment suppliers for medical devices — covering PVD, passivation, anodizing, DLC, plasma treatment, and antimicrobial coatings, with guidance on supplier audit, process validation (IQ/OQ/PQ), ASTM and ISO specification control, dimensional impact planning, biocompatibility evidence, quality agreement structure, and ongoing monitoring under FDA QMSR, ISO 13485, and EU MDR.

How to qualify a contract cleanroom assembly vendor for medical device manufacturing — cleanroom classification matching, environmental monitoring verification, gowning qualification, quality agreement requirements, audit approach, and ongoing oversight under ISO 13485, FDA QMSR, and EU MDR.

How to qualify a contract packaging vendor for medical device manufacturing — ISO 11607 validation capabilities, sterile barrier system expertise, seal process controls, labeling compliance, sterilization coordination, quality agreement requirements, and ongoing vendor oversight under ISO 13485, FDA QMSR, and EU MDR.

How to build and operate a quality management system for depot repair of reusable medical device capital equipment — receiving and triage, decontamination and biohazard protocols, diagnostic testing, repair and rework controls, calibration traceability, nonconformance handling, return-to-service release criteria, documentation requirements under FDA QMSR and ISO 13485, and audit readiness for depot service facilities.

How to qualify and manage enzyme suppliers for PCR and RT-qPCR in vitro diagnostic kits — covering Taq polymerase, hot-start variants, reverse transcriptase, lot-to-lot testing protocols, incoming acceptance specifications, stability requirements, change notification, and regulatory expectations under FDA QMSR, ISO 13485, and EU IVDR.

How to prepare an IVD CDMO technology transfer readiness package — documentation requirements, process validation ownership, quality agreement structure, analytical method transfer, regulatory filing strategy, and risk mitigation under FDA 21 CFR 820/QMSR, ISO 13485, and EU IVDR.

How to transfer a legacy medical device from in-house or incumbent manufacturing to a CDMO — DMR and DDF handoff, tacit knowledge capture, gap analysis between equipment sets, first article inspection, process validation requalification, change control under FDA QMSR and ISO 13485, regulatory notification strategy, and timeline planning.

How to design, manufacture, and stabilize lyophilized (freeze-dried) reagents for in vitro diagnostic kits — covering lyophilization process optimization, formulation excipients, lyo-bead and lyo-cake formats, fill-finish humidity control, residual moisture specification, accelerated and real-time stability studies, ICH Q1A application, container closure integrity, and regulatory expectations for FDA, EU IVDR, and ISO 13485.

How to select, qualify, and control magnetic beads, polystyrene latex particles, and gold nanoparticles as critical raw materials for IVD assays — covering chemiluminescent immunoassay (CLIA) magnetic beads, immunoturbidimetric latex particles, lateral flow gold colloid, particle characterization specifications, lot-to-lot bridging, conjugation chemistry, supplier qualification, and regulatory expectations under FDA QMSR, ISO 13485, and EU IVDR.

How to manage medical-grade resin raw material changes — including supplier change notifications, biocompatibility re-evaluation, process revalidation, regulatory filing strategy, and dual sourcing qualification — under FDA QMSR, ISO 13485, EU MDR, and ISO 10993.

How to select materials and suppliers for microfluidic cartridges and diagnostic tapes in IVD devices — covering COC, COP, PMMA, PC, and PP polymer properties, Solventum/3M diagnostic tape families (9792R, 9793R, 9795R, 9964, 9965, 9972A), injection molding and hot embossing for microfluidic features, bonding techniques (laser welding, thermal bonding, adhesive lamination, ultrasonic welding), extractable and leachable testing, biocompatibility, channel design for manufacturing, supplier qualification under ISO 13485, and process validation for IVD cartridge production.

How to select nitrocellulose membranes for lateral flow assay IVD products — pore size, capillary flow rate, protein binding capacity, backing type, thickness, striping parameters, lot-to-lot qualification, and regulatory considerations under FDA and EU IVDR.

How to qualify off-the-shelf single-use components — Luer connectors, tubing sets, syringes, stopcocks, and catalog parts — under ISO 13485 purchasing controls, FDA QMSR, and EU MDR, including risk-based evaluation, biocompatibility evidence, incoming inspection strategy, and change control.

How to qualify and manage oligonucleotide, primer, and probe suppliers for PCR, RT-qPCR, and molecular diagnostic IVD kits — covering synthesis quality grades, purity specifications, lot release testing, contamination control, lot-to-lot bridging, change notification, and regulatory requirements under FDA QMSR, ISO 13485, and EU IVDR.